HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

ethylene

Also Known As:
ethene
Networked: 817 relevant articles (15 outcomes, 68 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Huang, Rongfeng: 9 articles (10/2011 - 05/2004)
2. Nürnberger, Thorsten: 8 articles (11/2014 - 12/2006)
3. Zhang, Zhijin: 7 articles (10/2011 - 05/2004)
4. Miller, Stephen D: 6 articles (03/2014 - 04/2002)
5. Baldwin, Ian T: 5 articles (08/2011 - 06/2007)
6. Seo, Shigemi: 5 articles (11/2009 - 11/2006)
7. Hwang, Byung Kook: 5 articles (11/2009 - 08/2004)
8. Ohashi, Yuko: 5 articles (11/2009 - 11/2006)
9. Ezura, Hiroshi: 5 articles (04/2007 - 04/2004)
10. Wang, Min: 4 articles (01/2015 - 02/2006)

Related Diseases

1. Neoplasms (Cancer)
2. Smear Layer
3. Wounds and Injuries (Trauma)
4. Pain (Aches)
02/01/2012 - "Seventeen consecutive rheumatoid arthritic outpatients with metatarsal pain participated in this repeated measures study of 7-mm flat Ethylene Vinyl Acetate, custom molded and dynamic impression insoles. "
07/01/2011 - "The conditions that were found to improve periapical healing significantly were: the preoperative absence of a periapical lesion (P = 0.003); in presence of a periapical lesion, the smaller its size (P ≤ 0.001), the better the treatment prognosis; the absence of a preoperative sinus tract (P = 0.001); achievement of patency at the canal terminus (P = 0.001); extension of canal cleaning as close as possible to its apical terminus (P = 0.001); the use of ethylene-diamine-tetra-acetic acid (EDTA) solution as a penultimate wash followed by final rinse with NaOCl solution in 2°RCTx cases (P = 0.002); abstaining from using 2% chlorexidine as an adjunct irrigant to NaOCl solution (P = 0.01); absence of tooth/root perforation (P = 0.06); absence of interappointment flare-up (pain or swelling) (P =0.002); absence of root-filling extrusion (P ≤ 0.001); and presence of a satisfactory coronal restoration (P ≤ 0.001). "
10/01/2005 - "Systemic metabolic radiotherapy for pain treatment, using samarium-153 ethylene diamine tetramethylene phosphonic acid (Sm-153-EDTMP) can be offered to patients with painful metastatic osteosarcoma or in case of recurrent bone sites inaccessible to local therapies (surgery, external irradiation)."
01/01/2013 - "Bone-seeking radionuclides including samarium-153 ethylene diamine tetramethylene phosphonate and strontium-89 have been used for decades in the palliation of pain from bone metastases especially from prostate cancer. "
05/01/2005 - "Due to the fact that the existing commercial analgesic drugs are not able to reduce effectively the pain caused by the metastatic bone disease, the use of radiopharmaceuticals with avidity to selectively localize in the metastatic skeletal sites, such as strondium-89 chloride (89Sr-Cl2), rhenium-186-hydroxy ethylene diphosphonate (186Re-HEDP), and samarium-153-ethylene diamine tetramethylene (153Sm-EDTMP), is widely accepted. "
5. Hypersensitivity (Allergy)

Related Drugs and Biologics

1. Edetic Acid (EDTA)
2. Chelating Agents
3. Deferoxamine (Desferal)
4. Acetic Acid (Vinegar)
5. Abscisic Acid
6. Glycine (Aminoacetic Acid)
7. Gallium
8. Parathyroid Hormone (Parathormone)
9. Dimethyl Sulfoxide (DMSO)
10. Bicarbonates (Hydrogen Carbonate)

Related Therapies and Procedures

1. Intravenous Injections
2. Enzyme Replacement Therapy
3. Denture Rebasing
4. Transplants (Transplant)
5. Injections